StonvexLoading…
StonvexStonvexStonvexCore line items from SBSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $102.26M | $403.07M | $300.75M | $198.85M |
Operating Income | $28.30M | $82.63M | $57.86M | $52.76M |
Net Income | $23.26M | $69.22M | $48.23M | $21.81M |
EPS (Diluted) | $0.78 | $2.29 | $1.59 | $1.42 |
Total Assets | $8.80B | $8.51B | $8.38B | $8.34B |
Total Liabilities | $7.95B | $7.67B | $7.55B | $7.53B |
Cash & Equivalents | $387.47M | $389.79M | $466.91M | $390.10M |
Free Cash Flow OCF − CapEx | $44.99M | $73.48M | $56.89M | $19.52M |
Shares Outstanding | 29.83M | 30.23M | 30.32M | 30.40M |